Sort
64,565 grants matching “drug discovery”
Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells
$699,716Yadong Huang · J. David Gladstone Institutes · R01 · FY2020 · AG
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$699,605Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2023 · AI
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$699,605Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2022 · AI
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$699,605Ralph Mazitschek · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AI
A two-photon ophthalmoscope for human retinal imaging and functional testing
$699,501Krzysztof Palczewski · Case Western Reserve University · U01 · FY2016 · EY
ECOLOGICALLY GUIDED BIOPROSPECTING IN PANAMA
$699,500Smithsonian Institution · U01 · FY2002 · TW
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis
$699,460Magdalena Karbowniczek · Texas Tech University Health Scis Center · R01 · FY2023 · HL
Cannabinergic Medications for Methamphetamine Addiction
$699,373Alexandros Makriyannis · Northeastern University · R37 · FY2012 · DA
Discovery of long-acting, chemoprotective antimalarial compounds
$699,371Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2022 · AI
New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior
$699,342Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Expeditions: Collaborative Research: Understanding the World Through Code
$699,331Noah Goodman · Stanford University · · FY2020 · CSE
Core--Drug Screening and Chemistry Facility
$699,290Burnham Institute For Medical Research · P01 · FY2005 · AI
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing
$699,155Erik J Forsberg · Regenerative Medical Solutions, Inc. · R44 · FY2015 · DK
MRI: Acquisition of a GPU-Accelerated Cluster, High Performance Rio Grande Valley Cluster (HiRGV)
$699,077Nikolaos Dimakis · The University Of Texas Rio Grande Valley · · FY2020 · CSE
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.
$699,018Michael Mullan · Archer Pharmaceuticals, Inc. · R42 · FY2021 · AG
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
$698,980Stephen A Spector · University Of California, San Diego · R01 · FY2014 · NS
Behavioral Phenotyping Core
$698,956Leona Gagnon · Jackson Laboratory · P50 · FY2024 · DA
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
$698,955Michael M. Ittmann · Baylor College Of Medicine · U01 · FY2011 · CA
Acquisition of Nanion SyncroPatch 384PE
$698,907Roger D Cone · University Of Michigan At Ann Arbor · S10 · FY2019 · OD
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$698,840William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2016 · GM
Mutagenic And Toxic Effects Of Base Analogs
$698,820Roeland Schaaper · Environmental Health Sciences · Z01 · FY2007 · ES
Genetics & Clinical Cohorts
$698,804Sarah Jane Dunstan · University Of Washington · U19 · FY2021 · AI
ncRNA: structure, function and inhibition
$698,758Gabriele Varani · University Of Washington · R35 · FY2023 · GM
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
$698,736Suzee Eurie Lee · University Of California, San Francisco · R01 · FY2020 · AG
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
$698,710Joseph D Smith · Seattle Children'S Hospital · R01 · FY2021 · AI